Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Lymphovascular invasion (LVI) and perineural invasion (PNI) are independent prognostic factors in patients with colorectal cancer (CRC). In this study, we aimed to develop and validate a preoperative predictive model based on high-throughput radiomics features and clinical factors for accurate prediction of LVI/PNI in these patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Two hundred and sixty-three patients who underwent colorectal resection for histologically confirmed CRC between 1 February, 2011 and 30 June, 2020 were retrospectively enrolled. Between 1 February, 2011 and 30 September, 2018, 213 patients were randomly divided into a training cohort (n=149) and a validation cohort (n=64) by a ratio of 7:3. We used a 10000-iteration bootstrap analysis to estimate the prediction error and confidence interval for two cohorts. The independent test cohort consisted of 50 patients between 1 October, 2018 and 30 June, 2020. Regions of interest (ROIs) were manually delineated in high-resolution T2-weighted and diffusion-weighted images using ITK-SNAP software on each CRC tumour slice. In total, 3356 radiomics features were extracted from each ROI. Next, we used the maximum relevance minimum redundancy and least absolute shrinkage and selection operator algorithms to select the strongest of these features to establish a clinical-radiomics model for predicting LVI/PNI. Receiver-operating characteristic and calibration curves were then plotted to evaluate the predictive performance of the model in the training, validation and independent test cohorts.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A multi-parametric clinical-radiomics model combining MRI-reported extramural vascular invasion (EMVI) status and a Rad-score for the LVI/PNI estimation was established. This model had significant predictive power in the training cohort (area under the curve [AUC] 0.91; 95% confidence interval [CI]: 0.85–0.97), validation cohort (AUC: 0.88; 95% CI: 0.79–89) and independent test cohorts (AUC 0.83, 95% CI 0.72–0.95). The model performed well in the independent test cohort with sensitivity of 0.818, specificity of 0.714, and accuracy of 0.760. Calibration curve and decision curve analysis demonstrated clinical benefits.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Multiparametric clinical-radiomics models can accurately predict LVI/PNI in patients with CRC. Our model has predictive ability that should improve preoperative diagnostic performance and allow more individualised treatment decisions.</p></section>

Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapy

Clinical-radiomics nomogram for the risk prediction of esophageal fistula in patients with esophageal squamous cell carcinoma treated with intensity-modulated radiation therapy or volumetric-modulated arc therapy

Prediction of esophageal fistula in radiotherapy/chemoradiotherapy for patients with advanced esophageal cancer by a clinical-deep learning radiomics model

Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram

Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer

Quantitative CT Analysis to Predict Esophageal Fistula in Patients with Advanced Esophageal Cancer Treated by Chemotherapy or Chemoradiotherapy

Radiomics Analysis of Contrast-Enhanced CT for the Preoperative Prediction of Microvascular Invasion in Mass-Forming Intrahepatic Cholangiocarcinoma

Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients

Incorporation of PET Metabolic Parameters With Clinical Features Into a Predictive Model for Radiotherapy-Related Esophageal Fistula in Esophageal Squamous Cell Carcinoma

A 18F-FDG PET/CT-based Deep Learning-Radiomics-clinical Model for Prediction of Cervical Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma

Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective

Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy

Developing and validating multi-omics prediction models for late patient-reported dysphagia in head and neck radiotherapy

Risk Factors for Esophageal Fistula in Esophageal Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis

Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site

A clinical‐radiomics model incorporating T2‐weighted and diffusion‐weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer

Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial

Computed tomography-based multi-organ radiomics nomogram model for predicting the risk of esophagogastric variceal bleeding in cirrhosis